Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
»
April 21 2021 - Biopharma ramps up lobbying spend as drug pricing legislation nears
Flag link:
Biopharma ramps up lobbying spend as drug pricing legislation nears
Biopharma ramps up lobbying spend as drug pricing legislation nears
Endpoints
drug pricing
lobbying
legislation
GSK
Teva Pharmaceutical
Merck
JNJ
Flag link:
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
CP WIre
philanthropy
physicians
environmental concerns
Flag link:
Roche sees a slight dip in Q1 as biosimilars keep biting into blockbuster oncology trio's sales
Roche sees a slight dip in Q1 as biosimilars keep biting into blockbuster oncology trio's sales
Endpoints
Roche
earnings
biosimilars
Flag link:
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Fierce Biotech
Roche
antibodies
COVID-19
Flag link:
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Pharmaceutical Business Review
JNJ
vaccines
COVID-19
Europe
blood clots
Flag link:
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Regeneron
antibodies
COVID-19
Flag link:
FDA offers scathing review of Emergent plant's sanitary conditions, employee training after halting production
FDA offers scathing review of Emergent plant's sanitary conditions, employee training after halting production
Endpoints
FDA
Emergent BioSolutions
regulatory inspections
drug manufacturing
vaccines
Flag link:
Biogen Reports New Spinraza Data in SMA
Biogen Reports New Spinraza Data in SMA
Global Genes
Biogen
Spinraza
SMA
Flag link:
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
COVID-19
vaccines
CDC
Flag link:
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
NIH
NIH
clinical trials
drug repurposing
COVID-19
Flag link:
Regulatory progress for two biotechs stalls as FDA requests more information
Regulatory progress for two biotechs stalls as FDA requests more information
MedCity News
KalVista
Y-mAbs Therapeutics
FDA
KVD824
HAE
Flag link:
AAN 2021 – Helios backs Alnylam’s sunny forecasts
AAN 2021 – Helios backs Alnylam’s sunny forecasts
EP Vantage
Alnylam
AAN
vutrisiran
Onpattro
hATTR amyloidosis
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Key Account Manager
Flag link:
Regional Equine Key Account Manager
Flag link:
Territory Manager
Flag link:
Territory Manager
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »